David J. Tanzer, Md

David J. Tanzer, Md Email and Phone Number

Chief Medical Officer @ Lexitas Pharma Services
San Diego, CA, US
David J. Tanzer, Md's Location
San Diego, California, United States, United States
David J. Tanzer, Md's Contact Details

David J. Tanzer, Md work email

David J. Tanzer, Md personal email

About David J. Tanzer, Md

OVERVIEW:I have over 20 years of broad-based leadership experience spanning private sector companies (Johnson & Johnson, Abbott, Novartis, and OcuTerra), non-profits, and military organizations. My specialties include Global Medical Affairs, Clinical Development, Safety, Commercialization and Launch Excellence, Compliance, and Quality Assurance within the medical / healthcare field.I am successful in creating immediate and lasting value for organizations through my field credibility and proven leadership performance. Leveraging a diverse medical/surgical, research, and corporate executive leadership background, I bring a holistic, business-oriented, patient-centered, and customer-focused approach to strategic planning and operations growth. With a combination of a big-picture vision and boots-on-the-ground execution, I build and develop the teams, systems, regulatory controls, and processes that set organizations on a path of continued success. My strong understanding of the device and drug development and commercialization processes includes comprehensive experience in outcomes research and payor access issues. I have extensive experience in Medical Affairs and Clinical Research, clinical trial design and management, and overall scientific expertise. Throughout my career, I have built a record of success in support of launch excellence, commercial product and market growth, and safety through the development and strengthening of Global Medical Affairs and Clinical Development organizations and execution. A prolific author, compelling presenter, and strong partnership builder, I foster mutually beneficial relationships with executives, colleagues at all levels, key partners, and various industry professionals and societies. Leading by example, I inspire individuals and organizations to achieve highly ambitious goals.HIGHLIGHTS:★ OcuTerra: Driving clinical development of a first-in-class, topical therapy for chorioretinal vascular disease.★ Novartis: Instrumental driver of $6B blockbuster worldwide launch of revolutionary therapy for macular degeneration by integrating the value of Global Medical Affairs as a pivotal function.★ J&J Vision / Abbott Medical Optics: Critical role in building Global Medical Affairs as a vital contributor to commercial success.★ GWS / TLC, Inc.: Key contributor to growth of the most reputable anterior segment practice in San Diego.★ Naval Medical Center San Diego: Primary developer and leader of a world-renowned, high-impact Refractive Surgery Program.

David J. Tanzer, Md's Current Company Details
Lexitas Pharma Services

Lexitas Pharma Services

View
Chief Medical Officer
San Diego, CA, US
Website:
lexitas.com
Employees:
119
David J. Tanzer, Md Work Experience Details
  • Lexitas Pharma Services
    Chief Medical Officer
    Lexitas Pharma Services
    San Diego, Ca, Us
    View
  • Ocuterra Therapeutics
    Chief Medical Officer | Executive Vice President - Clinical And Medical Affairs
    Ocuterra Therapeutics Jun 2021 - Present
    I am thrilled and honored to share that I have joined OcuTerra Therapeutics as Chief Medical Officer and Executive Vice President, Clinical and Medical Affairs. I am privileged to report directly to Kerrie Brady, our President and Chief Executive Officer, and have the opportunity to interact closely with our esteemed Board of Directors, led by Brent Saunders (Executive Chair) and Bill Koster (Vice Chair). OcuTerra is a Boston-based, clinical stage, ophthalmology drug development company, focused on improving the way we manage ocular pathology. Beginning with our lead candidate compound, OTT166, we are striving to provide patients and their clinicians with a topical (eye drop) treatment for vascular-related diseases of the eye, including diabetic retinopathy, via a novel mechanism of action involving selective integrin inhibition. Being a topical treatment, OTT166 could potentially for the first time enable clinicians to provide treatment for patients suffering from chorioretinal vascular disease earlier in the disease process to prevent or slow down disease progression. Following successful phase 1b studies demonstrating a remarkably clean safety profile and strong evidence of biologic effect in patients, we are swiftly moving into phase 2 studies to confirm safety and further evaluate efficacy across a dose-response range, beginning with diabetic retinopathy.I am ecstatic to work with the OcuTerra team and our Medical Advisory Board, including David Boyer, Jeff Heier and Peter Kaiser, to accelerate our progress in developing innovative drugs for ophthalmic disease for which the current standard of care does not prevent or control the progression of disease.www.ocuterratx.com
    View
  • Phoenix Medical And Consulting Services, Apc
    President
    Phoenix Medical And Consulting Services, Apc 2017 - Present
    OVERVIEW:Functions as both the company President and in multiple independent consulting roles, including Global Medical Affairs Consultant, Ophthalmology Medical and Surgical Expert, and Premium Practice Consultant. Professional medical corporation servicing clients in the San Diego and surrounding areas.HIGHLIGHTS:★ Maintains worldwide reputation as a Key Opinion Leader in ophthalmology, industry Subject Matter Expert, and Global Medical Affairs professional.
  • Novartis
    Global Executive Medical Director, Ophthalmology
    Novartis 2018 - 2021
    Basel, Baselstadt, Ch
    OVERVIEW:Recruited and hired based on unparalleled experience as a clinician, clinician scientist, podium presenter and peer-reviewed author, and multi-industry executive leader. Spearheaded efforts on the worldwide launch of Beovu (multibillion-dollar blockbuster brand), the next-generation, anti-VEGF therapy for neovascular age-related macular degeneration with additional indications to follow. Led and coached a global team of 6 Global Medical Affairs Directors and a Scientific Excellence in Communications Director. Guided comprehensive post-launch data generation, dissemination, and medical expert engagement plan, including peer-reviewed publications, podium presentations, symposia, and medical education initiatives. Managed 8-figure budget, oversaw 2 global Phase 3 clinical trials and facilitated 7 additional Phase 4 post-launch studies. Drove strategic development and tactical deployment of the Medical Insights function, including advisory boards, steering committees, MSL training, and field insights.Challenges: Enabled organization-wide recognition of the unique value of Medical Affairs to support the Beovu launch and maintained continued investment in the data generation and dissemination plan. Navigated through a highly matrixed, immense corporate environment while leveraging the unique perspective of Medical Affairs to the global launch.
    View
  • Novartis
    Global Executive Medical Director, Ophthalmology
    Novartis 2018 - 2021
    Basel, Baselstadt, Ch
    HIGHLIGHTS:★ Raised the profile and positioning of GMA as an integrated 3rd pillar between Commercial and Development, driving value via data generation/dissemination and medical insights. Increased the GMAD team to 6 and brought the SEC function under the Global Brand Medical Director.★ Led efforts as the first brand to use STEM leadership and medical evaluation process within a pre-launch phase to measure the impact of the medical field force and alignment with the commercial team at CPO, regional, and global levels. ★ Facilitated high-impact presentations at all key global congresses as well as key regional and CPO-level meetings, resulting in 3x the number of presentations on Beovu in the launch year vs. Eylea.★ Achieved critical Phase 3b study 1 month ahead of plan. Mitigated supply issue impact in the U.S. by increasing additional country involvement and opening additional sites to lessen risk of Data Base Lock impact.★ Introduced a Field Medical Intelligence tool used to gather important Medical Expert insights from MSLs (shared at a global level) to evaluate adoption of critical medical messages and concerns.★ Drove a high-impact Medical Expert Engagement Plan that involved 2 Expert Retina Council face-to-face meetings, numerous regional and CPO-level engagements with over 200 of the world’s top retina specialists, and 10 EC workstream TCs.★ Led GMAT in reviewing and endorsing Phase IV protocols from the U.S., Canada, Switzerland, Germany, Italy, and France (aligned with global strategy) to close data gaps and support the Beovu worldwide launch.★ Played key role in finalizing the review and approval of the PCV study to support the launch of Beovu in Japan, as well as addressing a key data gap of efficacy and safety of Beovu.★ Gained an additional 10 podium presentations and 4 manuscripts generated in 2019 to support the Beovu launch through the FRB! Project as well as other large, global datasets.
    View
  • Johnson & Johnson Vision
    Chief Medical Officer / Divisional Vp, Global Medical Affairs, J&J Vision
    Johnson & Johnson Vision 2013 - 2017
    Jacksonville, Fl, Us
    OVERVIEW:Recruited and hired from successful private practice to join the Abbott Medical Optics executive team as the inaugural Chief Medical Officer, with the primary goal of creating a brand-new Global Medical Affairs operations and team. Led, coached, and evaluated cross-functional team of over 30, reporting to the CEO. Planned and administered 8-figure annual budget. Directed all global product launch support, safety surveillance and recall support functions for the entire organization. Served as a signatory on all Clinical Evaluation Reports (over 50 annually) and a member of Executive Staff Quality Review Meetings (quarterly). As the in-house clinical expert, contributed key input to monthly product Post-Market Surveillance meetings.HIGHLIGHTS:★ Built Global Medical Affairs as a separate entity. Created and filled Global Medical Director, Cataract and Global Medical Director, Refractive Surgery positions. Seized leadership of Global Phase IV study team, global Clinical Management team, and Global Grants Committee.★ United previously disparate functions under Global Medical Affairs and instilled a high level of clinical credibility to support the company’s Commercial businesses worldwide.★ Triggered significant increase in productivity for Global Phase IV studies, publications, and presentations, including 124 ongoing studies, 73 peer-reviewed publications, and 1,000s of media impressions in trade journals by the end of 2016. ★ Ensured safe, effective use of products and devices by establishing new certification and annual recertification processes for all physician customers adopting AMO technologies.★ Ensured adoption of “Voice of the Physician Customer” philosophy organization-wide by convening and facilitating high-impact global and regional Medical Advisory Boards.★ Played critical role in reducing outstanding product complaints by 50+% and decreasing number of field actions requiring a product recall by 40% between 2013 and 2017.
    View
  • Johnson & Johnson Vision
    Chief Medical Officer / Divisional Vp, Global Medical Affairs, J&J Vision
    Johnson & Johnson Vision 2013 - 2017
    Jacksonville, Fl, Us
    HIGHLIGHTS (continued):★ Leveraged medical, clinical, and surgical subject matter expertise to drive product safety improvements on a global basis. Served as a member of every action team convened during product recalls to evaluate and address regulatory, commercial, and customer needs.★ Upheld the company’s impeccable reputation for product safety and utilized a Subject Matter Expert within the organization vs. reliance on external consultants as safety monitors.★ Engaged in a comprehensive, around-the-clock effort to raise the contribution of the Medical Affairs work product to the success of the business, including peer-to-peer communications, key opinion leader management, and the strategic study-presentation-publication matrix.★ Enabled executive leaders and cross-functional teams, including Sales and Marketing, to realize the tangible value that Medical Affairs brought to the entire organization. Gained annual 5-10% budget increase based on acknowledgement of its positive impact.★ Increased support for Medical Affairs activities, including Phase IV studies and resulting publications/presentations, communications between internal experts and physician customers, and continued quality training of physicians.★ Chaired the cross-functional committee that reviewed and approved all grant proposals submitted for independent medical education support and non-promotional corporate support. Served as a member of the executive staff-level New Product Committee (NPC) that reviews and approves all product development initiatives.★ Maintained high level of focus and productivity for the Medical Affairs team during an extremely challenging integration with larger parent company Johnson & Johnson.★ Generated 6-figure reduction in external annual monitor costs by serving as the Medical Monitor for over 30 Phase III studies on various cataract and refractive surgery products.
    View
  • Gordon Weiss Vision Institute
    Associate Physician & Surgeon
    Gordon Weiss Vision Institute 2012 - 2013
    OVERVIEW:Joined the organization following its purchase of TLC San Diego (on track to becoming Partner prior to joining AMO as a Chief Medical Officer- GWS is the premiere cornea, cataract, and refractive surgery practice in San Diego, providing 30+ years of service to the surrounding community). Served as the primary referral source for active duty military members and those seeking to join the military, evaluating and surgically correcting refractive disorders. Leveraged experience as an investigative surgeon (for a unique intraocular procedure to correct refractive errors and corneal abnormalities) to serve as a primary referral source for complex cases that could not be corrected with routine surgery.HIGHLIGHTS:★ Played key role in contributing to the development of the most reputable anterior segment practice in San Diego through direct referrals and expansion of the optometric co-management network.★ Wrote articles and delivered lectures to demonstrate value to referral physicians and build a unique brand within this practice.★ Participated in multiple clinical trials for GWS, including a cornea cross-linking study which resulted in eventual FDA approval.
  • Tlc San Diego Inc
    President/Medical Director | Associate Medical Director
    Tlc San Diego Inc 2005 - 2012
    OVERVIEW:President / Medical Director (2011-2012)Associate Medical Director (2005-2011)Held full P&L accountability for all aspects of a start-up organization, directing a team of 8 (TLC San Diego is the premier ophthalmology practice dedicated to offering the highest quality services and latest technological advances in refractive surgery). Procured loans, negotiated partnership with senior faculty member from UCSD, and secured long-term commercial lease in a brand-new medical building, supervising construction of clinical and surgical spaces. Hired Practice Manager as well as all ancillary and support team members. Managed development and execution of marketing and branding strategies, including collateral materials.HIGHLIGHTS:★ Partnered with UCSD Shiley Eye Center Professor of Ophthalmology (well-known refractive surgery expert) to launch and build ophthalmology practice under the TLC brand that had been inactive in the San Diego region for several years.★ Grew ophthalmic surgical presence by co-managing 1,000s of refractive surgery patients with over 120 optometrists in the San Diego area.★ Facilitated TLC’s merger with GWS to create a larger, stronger organization. Oversaw the transition of personnel and assets, dissolved the commercial lease, and closed out all business loans.
  • Naval Medical Center San Diego
    Director | Specialty Leader | Staff Physician & Surgeon | Program Director
    Naval Medical Center San Diego 1998 - 2011
    OVERVIEW:Staff Physician & Surgeon, Department of Ophthalmology (2006-2011/1998-2005)Director, U.S. Navy Refractive Surgery Program (2006-2011)Specialty Leader/Navy Surgeon General’s Advisor for Refractive Surgery, Navy Bureau of Medicine & Surgery (2007-2010)Director, Navy Refractive Surgery Center, Department of Ophthalmology (2007-2010)Built a distinguished record of achievement through multiple roles within a prestigious medical treatment organization (the premier US Military Medical Center, delivering quality health services to 250K+ San Diego residents and ~100k enrolled beneficiaries).Selected for fellowship training in cornea and anterior segment ophthalmic surgery immediately following completion of ophthalmology residency in 6/1997 (only 1 of 3 such sub-specialists in the entire U.S. Navy). Progressed through leadership positions with increasing levels of responsibility throughout tenure.Held title of Program Director for final 5 years of tenure, along with selection as Surgeon General’s Advisor for Refractive Surgery. Tasked with providing leadership and direction for newly-created Navy Refractive Surgery Program (mission-critical initiative). Additionally oversaw training and development of medical students, interns, residents, and fellows. Maintained clinical and surgical schedule while leading efforts in research and presentation/publication of findings.
  • Naval Medical Center San Diego
    Director | Specialty Leader | Staff Physician & Surgeon | Program Director
    Naval Medical Center San Diego 1998 - 2011
    HIGHLIGHTS:★ Led sustained program growth and productivity over a 13-year period through a cross-functional effort, with 15K+ surgical procedures annually, over 70 IRB-approved protocols, and the approval of refractive surgery for Naval aviators, SEALs, and NASA astronauts.★ Served as a key catalyst in driving a Navy Refractive Surgery Program that had one of the largest impacts of any programs in medicine. The clinic and surgery facility became a Center of Excellence that was observed by visiting ophthalmologists from around the world.★ Increased dedicated program funding to 7-figure annual total while strengthening support from operational forces and industry partners.★ Impacted the practice of ophthalmology on a worldwide scale. Led research efforts and results that were reported and published globally, influencing ophthalmology techniques (research emulated by sister services and academic institutions such as Stanford and Johns Hopkins Wilmer Eye Institute).★ Trained 500+ medical students, interns, residents, fellows, and practicing ophthalmologists in clinical and surgical techniques related to cornea, cataract, and refractive surgery. Built a highly competent, knowledgeable, and innovative team through ongoing coaching and development.★ Completed over 25K corneal, cataract, and refractive surgical procedures throughout tenure. Earned certifications on 6 excimer lasers and 7 keratomes, including 4 femtosecond lasers.★ Earned multiple performance-based awards that included: Meritorious Service Medal (2005 and 2011); Navy/Marines Corps Commendation Medal (2001); and the Sydney D. Leverett, Jr. Environmental Science Award from the Aerospace Medical Association (2011).★ Wrote over 35 peer-reviewed journal articles and book chapters; delivered over 130 podium presentations at regional, national, and international conferences.
  • Us Navy
    Military Positions
    Us Navy 1991 - 2006
    Washington, Dc, Us
    MILITARY POSITIONS:★ Wing Surgeon - Marine Corps Air Station, Miramar, CA, Third Marine Aircraft Wing (III MAW) (2005-2006) – Established Trauma Combat Casualty Care (TCCC) course to instruct corpsmen and first responders in advanced trauma life support and medivac techniques within combat environments. Earned a Meritorious Service Medal, 12/06.★ Squadron Flight Surgeon - Marine Corps Air Station, El Toro, CA, Marine Fighter Attack Squadron (VMFA) 314 (1992-1994) – Accumulated over 500 flight hours in 17 different types of military aircraft, including 300 hours in the F/A-18 Hornet, 78 aircraft carrier-arrested landings, and 12 combat missions over Iraq. Earned Navy/Marine Corps Commendation Medal, 7/94. ★ Student Flight Surgeon - Naval Air Station, Pensacola, FL, Naval Aerospace Medical Institute (NAMI) (1991-1992) – Enrolled in intensive 6-month course, culminating in Naval Flight Surgeon designation. Received the Surgeon General’s Award as the “top overall performer.”★ General Medical Officer - Marine Corps Recruit Depot, San Diego, CA, Branch Medical Clinic (BMC) (1991) – Conducted general physical examinations.
    View

David J. Tanzer, Md Skills

Capital Equipment Cataract Surgery Clinical Research Clinical Trials Global Medical Affairs Product Development Product Launch Regional Kol Management Clinical Development Trial Design Budget Planning And Administration Long Term Strategic Planning Short Term Strategic Planning Regulatory Compliance Fda Compliance Capital And Project Planning Project Leadership Strategic Global Partnerships And Alliances Negotiations Project Lifecycle Management Team Building And Leadership New Market Penetration Matrixed Management Operations Development Team Building Product Safety Federal And State Regulatory Compliance Business Development Commercial Support Acquisition Integration Clinical Trial Execution Start Up Growth Strategic Partnerships Mergers And Acquisitions

David J. Tanzer, Md Education Details

  • Georgetown University School Of Medicine
    Georgetown University School Of Medicine
    Doctor Of Medicine - Md
  • University Of Southern California
    University Of Southern California
    External Ocular Disease And Refractive Surgery Fellowship
  • Naval Medical Center San Diego
    Naval Medical Center San Diego
    Transitional Internship / Ophthalmology Residency
  • Uc Santa Barbara
    Uc Santa Barbara
    Biopsychology
  • Uc Santa Barbara
    Uc Santa Barbara
    Pharmacology
  • Loma Linda University
    Loma Linda University
    Ophthalmology Residency Program
  • Uc San Diego
    Uc San Diego
    Shiley Eye Center
  • Uniformed Services University
    Uniformed Services University
    Assistant Professor Of Surgery
  • University Of Southern California
    University Of Southern California
    Doheny Eye Institute

Frequently Asked Questions about David J. Tanzer, Md

What company does David J. Tanzer, Md work for?

David J. Tanzer, Md works for Lexitas Pharma Services

What is David J. Tanzer, Md's role at the current company?

David J. Tanzer, Md's current role is Chief Medical Officer.

What is David J. Tanzer, Md's email address?

David J. Tanzer, Md's email address is dj****@****hoo.com

What schools did David J. Tanzer, Md attend?

David J. Tanzer, Md attended Georgetown University School Of Medicine, University Of Southern California, Naval Medical Center San Diego, Uc Santa Barbara, Uc Santa Barbara, Loma Linda University, Uc San Diego, Uniformed Services University, University Of Southern California.

What skills is David J. Tanzer, Md known for?

David J. Tanzer, Md has skills like Capital Equipment, Cataract Surgery, Clinical Research, Clinical Trials, Global Medical Affairs, Product Development, Product Launch, Regional Kol Management, Clinical Development, Trial Design, Budget Planning And Administration, Long Term Strategic Planning.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.